Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torcetrapib/atorvastatin in Homozygous Familial Hypercholesterolaemia
NCT00134511Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, open-label, single-arm trial of torcetrapib in homozygous familial hypercholesterolemia (HoFH), sponsored by Pfizer. Primary endpoint: Change in LDL-C and HDL-C. Started Mar 2005; status: completed.
02
Drugs
torcetrapib
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT00134511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134511.